- The most important zoonotic  central nervous system (CNS) diseases in human in Europe and Asia. 10,000 to 15,000 cases were reported per year.
- New endemic areas are resurging each year. The countries with highest incidence of disease are Lithuania, Slovenia, Czech Republic and Latvia. 
- An increase of cases has been observed in endemic areas but also the occurrence of sporadic cases in no-endemic areas.  2020 has the highest increase of the disease compared the previous three years.
- 2% of cases can lead to a fatal outcome.
- There are two vaccines licensed and available in Europe and recommended for individuals living, working or traveling within TBE-endemic Although clear guidelines for TBE vaccination are in place, compliance by individuals/healthcare providers is not known.
- Currently, there is no approved antiviral treatment or prevention of TBEV infections in humans.
